We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+2.16%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$119M
AUM Growth
+$3.11M
Cap. Flow
+$619K
Cap. Flow %
0.52%
Top 10 Hldgs %
22.99%
Holding
184
New
25
Increased
49
Reduced
67
Closed
21

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.48M
2
ADI icon
Analog Devices
ADI
+$1.13M
3
PRXL
Parexel International Corp
PRXL
+$1.1M
4
MSFT icon
Microsoft
MSFT
+$969K
5
JWN
Nordstrom
JWN
+$833K

Sector Composition

Rank Sector Weight
1 Industrials 18.45%
2 Healthcare 16.9%
3 Consumer Staples 13.84%
4 Financials 13.02%
5 Consumer Discretionary 11.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DAL icon
126
Delta Air Lines
DAL
$60.1B
$293K 0.25%
7,450
-700
-9% -$26.5K
DO
127
DELISTED
Diamond Offshore Drilling
DO
$291K 0.24%
+16,550
New +$332K
GD icon
128
General Dynamics
GD
$106B
$287K 0.24%
1,851
-899
-33% -$134K
PFSI icon
129
PennyMac Financial
PFSI
$4.02B
$287K 0.24%
16,900
PX
130
DELISTED
Praxair Inc
PX
$284K 0.24%
2,350
C icon
131
Citigroup
C
$226B
$282K 0.24%
5,962
-1,438
-19% -$65.4K
DVA icon
132
DaVita
DVA
$11.7B
$281K 0.24%
4,250
-825
-16% -$58.1K
GIS icon
133
General Mills
GIS
$19.7B
$275K 0.23%
4,300
-2,350
-35% -$163K
BC icon
134
Brunswick
BC
$5.28B
$268K 0.22%
+5,500
New +$263K
CL icon
135
Colgate-Palmolive
CL
$74.4B
$267K 0.22%
3,600
-3,700
-51% -$274K
UFI icon
136
UNIFI
UFI
$134M
$266K 0.22%
9,050
TYL icon
137
Tyler Technologies
TYL
$12.8B
$265K 0.22%
1,550
-1,426
-48% -$238K
HSBC.PRA
138
DELISTED
HSBC Holdings PLC, Inc. ADS(1/40 shr. 6.2% Non-Cum. Dlr. Pref. Shrs., Ser.A)
HSBC.PRA
$265K 0.22%
10,350
-50
-0.5% -$1.3K
RDN icon
139
Radian Group
RDN
$4.93B
$262K 0.22%
19,350
-4,000
-17% -$51.6K
VZ icon
140
Verizon
VZ
$196B
$259K 0.22%
4,983
+700
+16% +$37.6K
MXL icon
141
MaxLinear
MXL
$6.8B
$255K 0.21%
12,577
-10,823
-46% -$213K
CFG icon
142
Citizens Financial Group
CFG
$30.6B
$243K 0.2%
9,850
-1,000
-9% -$23K
GIL icon
143
Gildan
GIL
$10.6B
$243K 0.2%
8,700
-1,000
-10% -$29.5K
ABBV icon
144
AbbVie
ABBV
$435B
$240K 0.2%
3,808
-11,700
-75% -$757K
CNBKA
145
DELISTED
Century Bancorp Inc/Mass
CNBKA
$240K 0.2%
5,301
-779
-13% -$34.3K
WWAV
146
DELISTED
The WhiteWave Foods Company
WWAV
$239K 0.2%
4,400
ACC
147
DELISTED
American Campus Communities, Inc.
ACC
$237K 0.2%
+4,650
New +$239K
TRN icon
148
Trinity Industries
TRN
$2.38B
$234K 0.2%
+13,425
New +$221K
BX icon
149
Blackstone
BX
$110B
$231K 0.19%
9,050
+800
+10% +$21.1K
WMT icon
150
Walmart Inc
WMT
$890B
$226K 0.19%
9,411

Similar funds

New England Research & Management's Q3 2016 Portfolio in Review

As of Q3 2016, New England Research & Management held 184 positions worth $119M, up 2.7% from $116M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

New England Research & Management's Q3 2016 filing shows 25 new, 49 increased, 67 reduced and 21 closed positions. Its largest new stake was Installed Building Products: 19,900 shares worth $714K. The largest sale was Merck, an estimated $1.48M.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Staples.

  • New England Research & Management's largest Q3 2016 buy was Installed Building Products: 19,900 shares worth $714K.
  • New England Research & Management added most to Bristol-Myers Squibb in Q3 2016, an estimated $881K increase.
  • New England Research & Management's biggest Q3 2016 reduction was Merck, cutting an estimated $1.48M.
  • New England Research & Management fully exited Analog Devices in Q3 2016, selling an estimated $1.13M.
  • New England Research & Management's ten largest holdings make up 23% of its $119M portfolio in Q3 2016.
  • New England Research & Management opened 25 new positions and closed 21 in Q3 2016.
  • New England Research & Management's portfolio value rose 2.7% quarter-over-quarter to $119M.

Based on New England Research & Management's 13F filing for Q3 2016, filed 5 Oct 2016.